Table 6.

Clinical and economic effects of the vaccination programme

Results	Year					Five-year results
	1	2	3	4	5
Base scenario
Avoided hospitalized pneumonias	1,134	5,755	13,078	21,471	29,998	71,436
Avoided outpatient pneumonias	762	3,869	8,792	14,434	20,166	48,022
Avoided primary bacteremias	31	156	313	572	686	1,758
Avoided empyemas	0	2	4	8	9	24
Avoided meningitis	10	51	103	189	226	579
Avoided bacteremic pneumonias	71	363	728	1,330	1,594	4,087
Avoided contagions	2,008	10,196	23,018	38,004	52,680	125,906
Hospitalized pneumonia cost savings	2,247,819	11,411,544	25,933,983	42,577,699	59,486,125	141,657,169
Outpatient pneumonia cost savings	190,504	967,134	2,197,917	3,608,480	5,041,478	12,005,513
Primary bacteremias cost savings	125,824	639,232	1,281,675	2,341,411	2,807,267	7,195,409
Empyemas cost savings	2,486	12,628	25,319	46,254	55,457	142,145
Meningitis cost savings	113,513	576,685	1,156,266	2,112,310	2,532,584	6,491,358
Bacteremic pneumonias cost savings	387,336	1,967,803	3,945,487	7,207,762	8,641,848	22,150,236
Savings by all cases averted	3,067,481	15,575,025	34,540,648	57,893,917	78,564,759	189,641,830
Cost of vaccinations	15,197,172	15,197,172	15,197,172	15,197,172	15,197,172	75,985,862
Net healthcare cost	12,129,691	−377,853	−19,343,475	−42,696,744	−63,367,587	−113,655,968
Discounted net healthcare cost	12,129,691	−366,848	−18,233,081	−39,073,569	−56,301,280	−101,845,087